Prescription Drugs

Rep. Anna Eshoo, D-Calif., right, chair of the House Health Subcommittee, says President Donald Trump and Attorney General William Barr want to take a sledgehammer to health care, as she joins, from left, Rep. Lisa Blunt Rochester, D-Del., House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., at a Democratic event ahead of a House floor vote on the Health Care and Prescription Drug Package, at the Capitol in Washington, Wednesday, May 15, 2019. (AP Photo/J. Scott Applewhite)
May 16, 2019 - 7:07 pm
WASHINGTON (AP) — Democrats pushed legislation buttressing the 2010 health care law and curbing prescription drug prices through the House Thursday, advancing a bill that has no chance of surviving in the Senate or getting President Donald Trump's signature and seemed engineered with next year's...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 9:01 am
WASHINGTON (AP) — Those ever-present TV ads for prescription drugs will soon carry prices, too, the nation's top health official said Wednesday, responding to a public outcry for government action to restrain medication costs. Health and Human Services Secretary Alex Azar said the Trump...
Read More
A report released on Thursday, May 2, 2019, by the Congressional Budget Office is photographed in Washington. Budget experts for Congress say the Trump administration’s plan to reduce out-of-pocket drug costs for Medicare beneficiaries will cost taxpayers another $177 billion from 2020-2029. (AP Photo/Jon Elswick)
May 02, 2019 - 6:49 pm
WASHINGTON (AP) — The Trump administration's plan to ease the financial hit of prescription drugs prices for Medicare beneficiaries will cost taxpayers another $177 billion over 10 years, congressional budget experts said on Thursday. The estimates from the nonpartisan Congressional Budget Office...
Read More
In this Friday, April 26, 2019 photo, a box of RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial results Tuesday, April 30. (AP Photo/Wilfredo Lee)
April 30, 2019 - 2:27 pm
Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit expectations. Investors drove up Pfizer shares $1.20, or 3%, to $40.79 in early afternoon trading. Sales of breast cancer drug Ibrance and...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. As Congress and the Trump administration aim to curb spiraling drug costs, outside groups like the Alliance for Patient Access are raising their voices as they seek to sway the outcome. But not all of these organizations are clear about who they actually represent. Their names can obscure the source of the message and they’re cagey about where all of their money comes from. (AP Photo/Elise Amendola)
March 18, 2019 - 8:54 am
WASHINGTON (AP) — As ominous music plays in the background, the narrator of a radio ad warns that a Trump administration proposal to apply international pricing to certain Medicare drugs would be a nightmare for seniors. The one-minute spot is the handiwork of the Alliance for Patient Access, a...
Read More
March 12, 2019 - 5:58 am
MINNETONKA, Minn. (AP) — The nation's largest health insurer is expanding a program that passes rebates from drugmakers directly to the people that use their medications. Beginning next year, all employer-sponsored health care plans that use UnitedHealthcare must give point-of-sale discounts...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, prepare to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 12:42 pm
WASHINGTON (AP) — Drawing from their personal experiences, senators on Tuesday chastised drug company executives over the high cost of prescription drugs, as the company officials cautioned that heavy-handed congressional action could jeopardize medical breakthroughs going forward. Tuesday's Senate...
Read More
February 24, 2019 - 3:43 pm
WASHINGTON (AP) — With health care a top issue for American voters, Congress may actually be moving toward doing something this year to address the high cost of prescription drugs. President Donald Trump, Democrats trying to retire him in 2020, and congressional incumbents of both parties all say...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 11:50 pm
WASHINGTON (AP) — The Trump administration has unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar would eliminate behind-the...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 6:55 pm
WASHINGTON (AP) — The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar would eliminate...
Read More

Pages